Carol Conrad, MD, is the Medical Director of the Pediatric Lung and Heart-Lung Transplant Program, and Associate Professor of Pediatrics at Stanford University. While the number of children with cystic fibrosis requiring a double lung transplant are declining due to new therapies, each year, several children experience advanced end-stage lung disease requiring transplant. In this presentation, Dr. Conrad shares the history of pediatric transplant, the challenges and outcomes, and the future of transplant.
Filmed by Brandon Delgado and Alana Ocampo.
CF Community Voices is sponsored by Vertex Pharmaceuticals, Gilead Sciences and Chiesi USA.